I. Vind

发表

Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis

M. Fenger, A. Paerregaard, L. Riis, 2019, Scandinavian journal of gastroenterology.

F. Bendtsen, J. Burisch, B. Lo, 2019, United European gastroenterology journal.

Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease.

P. Munkholm, J. Johansen, P. Price, 2003, Scandinavian journal of gastroenterology.

Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy

P. Munkholm, F. Bendtsen, M. Andersson, 2014, The American Journal of Gastroenterology.

Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow Up in a Danish Population-Based Inception Cohort.

F. Bendtsen, J. Burisch, B. Lo, 2019, Journal of Crohn's & colitis.

Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort: An ECCO-EpiCom Study

C. O'Morain, V. Andersen, L. Kupčinskas, 2015, Inflammatory bowel diseases.

The risk of extra-intestinal cancer in inflammatory bowel disease: a systematic review and meta-analysis of population-based cohort studies.

J. Burisch, B. Lo, I. Vind, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

NOD2/CARD15 Gene Polymorphisms in Crohn’s Disease: A Genotype-Phenotype Analysis in Danish and Portuguese Patients and Controls

I. Christensen, L. Hougs, P. Munkholm, 2005, Digestion.

Impact of Enteral Supplements Enriched with ω–3 Fatty Acids and/or ω–6 Fatty Acids, Arginine and Ribonucleic Acid Compounds on Leptin Levels and Nutritional Status in Active Crohn’s Disease Treated with Prednisolone

I. Brandslund, P. Munkholm, H. Grønbæk, 2007, Digestion.

East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

N. Pedersen, E. Björnsson, V. Andersen, 2013, Gut.

Genetic and Environmental Factors in Monozygotic Twins with Crohn’s Disease and Their First-Degree Relatives: A Case Report

L. Hougs, P. Andersen, P. Munkholm, 2005, Digestion.

Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.

N. Pedersen, C. O'Morain, E. Bjornsson, 2014, Journal of Crohn's & colitis.

Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database

P. Munkholm, F. Bendtsen, P. Nørregaard, 2006, The American Journal of Gastroenterology.

Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort.

P. Munkholm, M. Gamborg, T. Jess, 2011, Journal of Crohn's & colitis.

Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort—An ECCO-EpiCom Study

C. O'Morain, V. Andersen, L. Kupčinskas, 2017, Journal of Crohn's & colitis.

Changes in Clinical Characteristics, Course, and Prognosis of Inflammatory Bowel Disease during the Last 5 Decades: A Population‐Based Study from Copenhagen, Denmark

P. Munkholm, E. Langholz, V. Binder, 2007, Inflammatory bowel diseases.

Edinburgh Research Explorer Copy number variation of scavenger-receptor cysteine-rich domains within DMBT1 and Crohn's disease

E. Nimmo, J. Satsangi, N. Prescott, 2018 .

Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study

F. Bendtsen, M. Andersson, T. Jess, 2016, Inflammatory bowel diseases.

Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with ω-3 or ω-6 fatty acids and corticosteroids

I. Brandslund, J. Frystyk, P. Munkholm, 2005 .

Omega‐3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega‐6 fatty acids

I. Brandslund, D. Hougaard, P. Munkholm, 2005, Alimentary pharmacology & therapeutics.

Does Pregnancy Change the Disease Course? A Study in a European Cohort of Patients with Inflammatory Bowel Disease

C. O'Morain, S. Vermeire, B. Moum, 2006, The American Journal of Gastroenterology.

Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease: authors’ reply

P. Munkholm, A. Paerregaard, I. Vind, 2012 .

The Danish National Registry for Biological Therapy in Inflammatory Bowel Disease

N. Thorsgaard, J. Kjeldsen, M. Larsen, 2016, Clinical epidemiology.

Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception Cohort

F. Bendtsen, J. Burisch, J. Colombel, 2017, Journal of Crohn's & colitis.

Paediatric onset inflammatory bowel disease is a distinct and aggressive phenotype—a comparative population‐based study

B. Lo, A. Paerregaard, M. Malham, 2019, GastroHep.

Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease – a population‐based study

P. Munkholm, A. Paerregaard, I. Vind, 2011, Alimentary pharmacology & therapeutics.

Validation of ulcerative colitis and Crohn’s disease and their phenotypes in the Danish National Patient Registry using a population-based cohort

J. Burisch, B. Lo, I. Vind, 2020, Scandinavian journal of gastroenterology.

Changes in Disease Behaviour and Location in Patients With Crohn’s Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort

M. Dubinsky, C. Siegel, F. Bendtsen, 2018, Journal of Crohn's & colitis.

Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population‐based cohort study

N. Uldbjerg, B. Bibby, C. Hvas, 2021, Alimentary pharmacology & therapeutics.

Follow-Up of Exocrine Pancreatic Function in Type-1 Diabetes mellitus

T. Hwang, Y. Jan, A. Zinsmeister, 2005, Digestion.

Sweet’s Syndrome – An Extraintestinal Manifestation in Inflammatory Bowel Disease

P. Munkholm, I. Vind, H. Ytting, 2005, Digestion.

Quality improvement in wellness reports in patients with Crohn’s disease

P. H. Petersen, I. Brandslund, H. Grønbæk, 2006 .

Genetic polymorphisms of mannan binding lectin (MBL), serum levels of MBL, the MBL associated serine protease and H-ficolin in patients with Crohn’s disease

S. Thiel, J. Jensenius, P. Munkholm, 2007, Gut.

Expression of the genes dualoxidase2, lipocalin 2 and regenerating islet-derived 1 alpha in Crohn's disease

B. Vainer, B. Dieckgraefe, J. Olsen, 2007, Scandinavian journal of gastroenterology.

The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis

A. Petersen, F. Bendtsen, L. Gluud, 2016, Scandinavian journal of gastroenterology.

Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe: The ECCO-EpiCom Cohort

C. O'Morain, V. Andersen, L. Kupčinskas, 2014, Inflammatory bowel diseases.

Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease, Copenhagen County and City 2003-2005.

S. Larsen, P. Andersen, P. Munkholm, 2008, Journal of Crohn's & colitis.

Alpha-Defensin DEFA1A3 Gene Copy Number Elevation in Danish Crohn’s Disease Patients

B. Vainer, P. Andersen, O. Nielsen, 2011, Digestive Diseases and Sciences.

Copy number variation of scavenger-receptor cysteine-rich domains within DMBT1 and Crohn's disease

E. Nimmo, J. Satsangi, N. Prescott, 2016, European Journal of Human Genetics.

Copy number variation of scavenger-receptor cysteine-rich domains within DMBT1 and Crohn's disease

Eld, E. Nimmo, J. Satsangi, 2016, European Journal of Human Genetics.

Increased abundance of proteobacteria in aggressive Crohn’s disease seven years after diagnosis

N. Sørensen, A. Petersen, K. Krogfelt, 2019, Scientific Reports.

Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003-2011—a Danish population-based cohort study.

P. Munkholm, F. Bendtsen, M. Andersson, 2014, Journal of Crohn's & colitis.

C. O'Morain, E. Björnsson, V. Andersen, 2014, Journal of Crohn's & colitis.

Inﬂiximab Dependency in a National Cohort of Children with Crohn’s Disease

P. Munkholm, S. Husby, A. Paerregaard, 2018 .

Infliximab Dependency in a National Cohort of Children with Crohn's Disease

P. Munkholm, S. Husby, A. Paerregaard, 2006, Journal of pediatric gastroenterology and nutrition.

The prevalence of genetic and serologic markers in an unselected European population‐based cohort of IBD patients

C. O'Morain, S. Vermeire, P. Munkholm, 2007, Inflammatory bowel diseases.

A 10-Year Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish Population-Based Inception Cohort.

F. Bendtsen, J. Burisch, B. Lo, 2019, Inflammatory bowel diseases.

Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn’s disease – a real-world two-center cohort study

J. Seidelin, F. Bendtsen, J. Burisch, 2021, European journal of gastroenterology & hepatology.

Toll‐like receptor‐induced granulocyte‐macrophage colony‐stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2‐dependent and ‐independent pathways

P. Rosenstiel, A. Till, P. Höllsberg, 2009, Clinical and experimental immunology.

The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010–2020

F. Bendtsen, J. Burisch, I. Vind, 2022, Crohn's & colitis 360.

Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study

J. Burisch, B. Lo, M. Julsgaard, 2018, European journal of gastroenterology & hepatology.

Low Risk of Unemployment, Sick Leave, and Work Disability Among Patients with Inflammatory Bowel Disease: A 7-year Follow-up Study of a Danish Inception Cohort

F. Bendtsen, M. Andersson, T. Jess, 2015, Inflammatory bowel diseases.

Systematic review and meta‐analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index

L. Peyrin-Biroulet, R. Leong, L. Gluud, 2018, Alimentary pharmacology & therapeutics.

Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids.

I. Brandslund, J. Frystyk, P. Munkholm, 2005, Scandinavian journal of gastroenterology.

Incidence, risk factors and evaluation of osteoporosis in patients with inflammatory bowel disease - a Danish population-based inception cohort with 10 years of follow-up.

F. Bendtsen, J. Burisch, B. Lo, 2020, Journal of Crohn's & colitis.

Discontinuation of Infliximab Therapy in Patients with Crohn’s Disease

J. Jahnsen, J. Dahlerup, T. Klausen, 2022, NEJM Evidence.

J. Dahlerup, C. Hvas, I. Vind, 2009, Clinical and experimental immunology.

Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.

N. Pedersen, C. O'Morain, E. Bjornsson, 2014, Journal of Crohn's & colitis.

High Accuracy in Classifying Endoscopic Severity in Ulcerative Colitis Using Convolutional Neural Network

C. Igel, F. Bendtsen, J. Burisch, 2022, American Journal of Gastroenterology.

Building an AI Support Tool for Real-time Ulcerative Colitis Diagnosis

B. Lo, I. Vind, Johan Burisch, 2024, 2404.08693.